Industry Insights: 2026 JP Morgan Healthcare Conference
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
-
Gesprochen von:
-
Von:
Über diesen Titel
Join Tyler Coulander and Alan Morris as they break down the key takeaways from the 2026 JP Morgan Healthcare Conference and explore what these industry trends mean for the DME sector. In this episode, they discuss five critical themes shaping the future of healthcare: health systems stabilization and how hospitals are getting back to basics with cost control and operational efficiency, AI's evolution from buzzword to proven ROI in documentation and clinical operations, the resurgence of M&A activity and why strategic partnerships are becoming increasingly important, the impact of GLP-1 medications on diabetes management and sleep apnea treatment, and navigating payer and policy dynamics including Medicare Advantage changes and the One Big Beautiful Bill. Whether you're looking to strengthen health system relationships, invest in AI strategically, or prepare for industry consolidation, this episode provides actionable insights to help DME providers stay ahead of the curve in 2026 and beyond.
